Publication | Closed Access

Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis

Clinical ImmunologyAutoimmune DiseaseImmunologyImmunization ResponsesAutoimmunityImmunologic DiseaseImmunosuppressionMultiple SclerosisImmunotherapyMedicineNatalizumab TreatmentMeaningful Effects